Medical device manufacturers must continuously monitor the safety and performance of their products after they reach the market. Regulatory authorities expect manufacturers to identify potential risks, analyse clinical data, and implement improvements whenever necessary. One of the most important documents supporting this process is the pms consultants report. It provides evidence that a medical device continues to meet safety and performance requirements throughout its lifecycle.A well-prepared periodic safety update report helps manufacturers demonstrate regulatory compliance while protecting patient health. It also supports transparency with notified bodies and competent authorities by presenting updated benefit-risk evaluations, post-market surveillance findings, and corrective actions.This guide explains the purpose, content, regulatory requirements, and best practices for preparing an effective safety update report for medical devices.
The term EUDAMED Registration refers to the Periodic Safety Update Report required under the European Union Medical Device Regulation (EU MDR 2017/745). The report summarises data collected through post-market surveillance activities and evaluates whether the device continues to perform safely as intended.Unlike pre-market documentation, the PSUR focuses on real-world performance after the product has been commercialised. Manufacturers gather information from complaints, customer feedback, clinical studies, vigilance reports, literature reviews, and trend analysis.The objective is to confirm that the device's benefits continue to outweigh any identified risks.
A periodic safety update report is a structured regulatory document that compiles post-market surveillance information over a defined reporting period.The report generally includes:
Rather than simply listing incidents, the report analyses patterns and evaluates whether new hazards have emerged.
The medical device industry is constantly evolving, making continuous monitoring essential.The PSUR offers several important benefits:
Continuous review allows manufacturers to detect potential safety concerns before they become widespread problems.
EU MDR requires manufacturers of Class IIa, IIb, and III devices to prepare PSURs according to defined schedules.
The report helps identify recurring issues that may require updates to risk management files.
Real-world user feedback often reveals opportunities to enhance product design, usability, or instructions.
Healthcare providers and regulators gain confidence knowing manufacturers actively monitor product performance.
Under EU MDR requirements:
Manufacturers must update the report at least annually.
Annual updates are generally required.
Reports should be updated when necessary and at least every two years.
Although a PSUR is generally not mandatory, manufacturers must still maintain effective post-market surveillance documentation.
A comprehensive PSUR combines data from multiple sources to provide a complete picture of device performance.Typical sections include:
Manufacturers estimate:
This information provides context when analysing incident frequency.
The report reviews:
Recurring trends receive particular attention.
Manufacturers summarise:
Authorities use this information to monitor product safety across markets.
Clinical literature, PMCF studies, and published research support ongoing safety evaluations.
The manufacturer determines whether the device continues to provide greater clinical benefits than associated risks.
The PSUR is one component of an overall Post-Market Surveillance (PMS) system.A complete PMS system includes:
The PSUR consolidates findings from all these activities into a structured regulatory report.
Many manufacturers face difficulties when preparing PSURs.
Information often comes from multiple departments including quality, regulatory affairs, customer service, and clinical teams.
Small changes may indicate larger safety concerns if not properly analysed.
Risk management files, technical documentation, clinical evaluation reports, and PSURs must all remain aligned.
Manufacturers must remain aware of evolving MDR guidance documents and notified body expectations.
Organisations can improve report quality by following several best practices.
Collect safety information throughout the year instead of waiting until reporting deadlines.
Use consistent procedures for complaints, vigilance reports, and clinical feedback.
Ensure every identified issue is evaluated against the device's risk management documentation.
Update literature reviews and PMCF findings regularly.
Quality and regulatory teams should verify data accuracy before submission.
Preparing a compliant PSUR requires expertise in regulatory requirements, clinical evaluation, risk management, and post-market surveillance.Experienced regulatory consultants can assist with:
Professional guidance reduces regulatory risks while improving report quality.
The PSUR medical devices process is an essential part of maintaining compliance under the EU Medical Device Regulation. Rather than serving as a simple reporting obligation, it demonstrates a manufacturer's commitment to continuous product safety, regulatory excellence, and patient protection.A well-prepared periodic safety update report combines post-market surveillance data, clinical evidence, complaint analysis, and risk management into a comprehensive document that supports ongoing compliance. By implementing robust surveillance systems and regularly reviewing safety information, manufacturers can strengthen product quality, meet regulatory expectations, and build long-term trust with healthcare professionals and regulatory authorities.
